Omolola Eniola-Adefeso

Ann Arbor, MI, United States of America

Omolola Eniola-Adefeso

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Michigan. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Omolola Eniola-Adefeso. Retrieved from https://idiyas.com/inventor/omolola-eniola-adefeso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Work of Omolola Eniola-Adefeso

Introduction

Omolola Eniola-Adefeso is a distinguished inventor based in Ann Arbor, MI, who has made significant contributions to the field of biomedical engineering. With two patents to her name, her groundbreaking research focuses on leveraging polymer particles to enhance therapeutic strategies for neutrophil-related disorders.

Latest Patents

Among her noteworthy patents is the invention of polymer particles designed to restrain neutrophil function. These innovative polymer particles are aimed at preventing, treating, and ameliorating a range of inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other conditions where neutrophils play a critical role. In addition, the patent includes methods for diagnosing neutrophil-related diseases or conditions, underscoring the potential impact of her work in medical diagnostics and treatment.

Career Highlights

Eniola-Adefeso is affiliated with the University of Michigan, where she actively engages in research that combines engineering principles with medical applications. Her work reflects an impressive intersection of innovation and science, making her a prominent figure within her field.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as William N. Kelley and Theodore Standiford. These partnerships not only enhance the scope of her research but also drive advancements in the treatment of debilitating conditions linked to neutrophils.

Conclusion

Omolola Eniola-Adefeso exemplifies the advancements being made at the intersection of engineering and medicine. Her patents demonstrate innovative approaches to managing and diagnosing neutrophil-related diseases, marking her as a pivotal contributor to healthcare innovation. As her research continues, the impact of her work promises to significantly improve therapeutic outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…